Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ardent Health Partners, Inc. ( (ARDT) ) has provided an update.
On June 16, 2025, Ardent Health, Inc. announced the immediate departure of David Schultz from his role as President of Hospital Operations. His exit is classified as a ‘Qualifying Termination’ under the company’s Executive Severance Plan, entitling him to severance benefits as outlined in the company’s proxy statement and previous filings.
The most recent analyst rating on (ARDT) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Ardent Health Partners, Inc. stock, see the ARDT Stock Forecast page.
Spark’s Take on ARDT Stock
According to Spark, TipRanks’ AI Analyst, ARDT is a Outperform.
Ardent Health Partners, Inc. shows strong financial performance, with improvements in profitability and cash flow. The earnings call provided positive insights, indicating effective growth strategies and operational improvements. However, mixed technical indicators and the absence of a dividend yield moderate the overall score. The company’s valuation suggests potential for appreciation, supported by a low P/E ratio.
To see Spark’s full report on ARDT stock, click here.
More about Ardent Health Partners, Inc.
Average Trading Volume: 361,903
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.85B
For detailed information about ARDT stock, go to TipRanks’ Stock Analysis page.